GoAI
Get started
Value HR Co.,Ltd. logo

Value HR Co.,Ltd.

6078.T

JPXHealthcareMedical - Healthcare Information Services

Open in GoAI

Latest quote

¥1,632

+¥42.00 · +2.64%

Aug 24, 2:36 PM JSTData delayed

6078.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Established in Tokyo, Japan, in 2001, Value HR Co.,Ltd. specializes in providing a wide array of healthcare services. The company is primarily involved in the conceptualization, development, operation, and administration of its Value Cafeteria welfare support system. For businesses, Value HR offers consultancy on establishing health insurance associations, industrial health services, welfare programs, and acts as an agent for medical checkups. Additionally, it supports health insurance societies and health checkup facilities with administrative outsourcing, temporary staffing solutions, health management and data analytics assistance, probate services, and electronic application system implementation. The company further provides bespoke systems, including a web-based metabo countermeasure support system, a stress check system, and a medical expense itemization notification system.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
JP
CEO
Michio Fujita
Listed since
Oct 4, 2013
Employees
970

Market position

Day range

Current ¥1,632

52-week range

Current ¥1,632

Open
¥1,600
Previous close
¥1,590
Volume
23.7K
1.01× average
Average volume
23.42K
Average daily volume
Market cap
43.6B JPY
Beta
0.07
Market reference 1
50-day average
¥1,487.22
+9.73% above average
200-day average
¥1,491.62
+9.41% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
42.63B JPY
P/E (TTM)
58.9×
P/B (TTM)
6.41×
P/S (TTM)
4.13×
EV / EBITDA
29.77×
Earnings yield
1.48%
Free cash flow yield
3.07%
Dividend yield
1.69%

Profitability & efficiency

Gross margin
28.49%
Operating margin
8.71%
Net margin
7.02%
Return on equity
9.12%
Return on assets
3.45%
Return on invested capital
5.03%

Financial health

Debt / equity
0.81×
Current ratio
1.02×
Altman Z-score
3.72
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends45%31%17%3%Gross margin, FY2021: 40.44%Gross margin, FY2022: 41.79%Gross margin, FY2023: 41.40%Gross margin, FY2024: 34.86%Gross margin, FY2025: 28.94%Operating margin, FY2021: 18.34%Operating margin, FY2022: 19.36%Operating margin, FY2023: 19.52%Operating margin, FY2024: 13.34%Operating margin, FY2025: 8.77%Net margin, FY2021: 11.99%Net margin, FY2022: 14.28%Net margin, FY2023: 13.66%Net margin, FY2024: 9.44%Net margin, FY2025: 6.25%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 40.44%. Gross margin FY2022 41.79%. Gross margin FY2023 41.40%. Gross margin FY2024 34.86%. Gross margin FY2025 28.94%. Operating margin FY2021 18.34%. Operating margin FY2022 19.36%. Operating margin FY2023 19.52%. Operating margin FY2024 13.34%. Operating margin FY2025 8.77%. Net margin FY2021 11.99%. Net margin FY2022 14.28%. Net margin FY2023 13.66%. Net margin FY2024 9.44%. Net margin FY2025 6.25%.

Income trends

Revenue

10.07B JPY+20.20%

Operating income

883.33M JPY-20.97%

Net income

629.02M JPY-20.49%
Income trends across reported periods11.01B JPY7.24B JPY3.46B JPY−314.91M JPYRevenue, FY2021: 5.53B JPYRevenue, FY2022: 6.17B JPYRevenue, FY2023: 7.1B JPYRevenue, FY2024: 8.38B JPYRevenue, FY2025: 10.07B JPYOperating income, FY2021: 1.01B JPYOperating income, FY2022: 1.19B JPYOperating income, FY2023: 1.39B JPYOperating income, FY2024: 1.12B JPYOperating income, FY2025: 883.33M JPYNet income, FY2021: 662.56M JPYNet income, FY2022: 880.81M JPYNet income, FY2023: 970.02M JPYNet income, FY2024: 791.07M JPYNet income, FY2025: 629.02M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 5.53B JPY. Revenue FY2022 6.17B JPY. Revenue FY2023 7.1B JPY. Revenue FY2024 8.38B JPY. Revenue FY2025 10.07B JPY. Operating income FY2021 1.01B JPY. Operating income FY2022 1.19B JPY. Operating income FY2023 1.39B JPY. Operating income FY2024 1.12B JPY. Operating income FY2025 883.33M JPY. Net income FY2021 662.56M JPY. Net income FY2022 880.81M JPY. Net income FY2023 970.02M JPY. Net income FY2024 791.07M JPY. Net income FY2025 629.02M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue10.07B JPY8.38B JPY7.1B JPY6.17B JPY5.53B JPY
Cost of goods sold7.15B JPY5.46B JPY4.16B JPY3.59B JPY3.29B JPY
Gross profit2.91B JPY2.92B JPY2.94B JPY2.58B JPY2.23B JPY
Selling, general, and administrative2.03B JPY1.8B JPY1.55B JPY1.38B JPY1.23B JPY
Operating expenses2.03B JPY1.8B JPY1.55B JPY1.38B JPY1.22B JPY
Interest income2.56M JPY209K JPY32K JPY27K JPY673K JPY
Interest expense60.02M JPY39.59M JPY33.03M JPY37.05M JPY41.55M JPY
Depreciation and amortization464.92M JPY375.7M JPY342.75M JPY310.18M JPY290.72M JPY
Operating income883.33M JPY1.12B JPY1.39B JPY1.19B JPY1.01B JPY
Net income629.02M JPY791.07M JPY970.02M JPY880.81M JPY662.56M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
4.57

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates16.3510.244.13-1.98Q4 '24Q1 '25Q2 '25Q3 '25Q3 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 6.22, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 11.64, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 6.02, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 12, 2025: actual -0.714, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 30, 2025: actual 3.16, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 15.09, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual 4.88, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 13, 2026: actual 4.57, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates2.95B2.68B2.42B2.16BQ1 '25No estimateQ2 '25No estimateQ3 '25No estimateQ3 '25No estimateQ1 '26No estimateQ2 '26No estimateQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 2.29B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 2.27B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 12, 2025: actual 2.46B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 30, 2025: actual 2.5B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 2.84B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual 2.56B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 13, 2026: actual 2.6B JPY, estimate 2.67B JPY, surprise -2.73%, Miss. Q4 2026, reported Nov 12, 2026: actual —, estimate 2.72B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥26.00

2025 complete year+112.2% since 2021

2026 partial: ¥14.50

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Dec 29, 2026

¥13.50

Semi-Annual

Record Dec 31, 2026 · Payment Dec 29, 2026

Dividend

Ex-dividend Jun 29, 2026

¥14.50

Semi-Annual

Record Jun 30, 2026 · Payment Aug 20, 2026

Dividend

Ex-dividend Dec 29, 2025

¥13.00

Semi-Annual

Record Dec 31, 2025 · Payment Mar 12, 2026

Dividend

Ex-dividend Jun 27, 2025

¥13.00

Semi-Annual

Record Jun 30, 2025 · Payment Aug 18, 2025

Dividend

Ex-dividend Dec 27, 2024

¥13.00

Semi-Annual

Record Dec 31, 2024 · Payment Mar 12, 2025

Dividend

Ex-dividend Jun 27, 2024

¥12.00

Semi-Annual

Record Jun 30, 2024 · Payment Aug 19, 2024

6078.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,989

-0.31%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,817

+0.92%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,030

+0.54%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,280

+0.70%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,405

+0.75%

ETFs holding 6078.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
69.48M
Weight
0.00%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥418.4+0.10%
Vanguard International Dividend Appreciation ETF logoVanguard International Dividend Appreciation ETFVIGI
Market value
246.22K
Weight
0.00%
AUM
9.4B USD
Expense ratio
0.07%
Price / 1D
$98.61+0.82%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
177.54K
Weight
0.00%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.545+0.71%
Dimensional - International Core Equity 2 ETF logoDimensional - International Core Equity 2 ETFDFIC
Market value
140.42K
Weight
0.00%
AUM
15.43B USD
Expense ratio
0.22%
Price / 1D
$39.405+0.83%
Dimensional World ex U.S. Core Equity 2 ETF logoDimensional World ex U.S. Core Equity 2 ETFDFAX
Market value
102.31K
Weight
0.00%
AUM
12.57B USD
Expense ratio
0.28%
Price / 1D
$38.16+0.82%
Dimensional - International Core Equity Market ETF logoDimensional - International Core Equity Market ETFDFAI
Market value
73.22K
Weight
0.00%
AUM
18.23B USD
Expense ratio
0.18%
Price / 1D
$43.35+0.81%

Continue in GoAI

Research 6078.T

research.disclaimer